Turn Therapeutics (Nasdaq: TTRX)

📍 Westlake Village, United States🗓 Founded 2015👥 11 employees💰 Last funded 2018
Pharmaceutical Manufacturing🌐 turntherapeutics.com
Website LinkedIn
Turn Therapeutics® is a a leader in inflammatory and infectious disease research. Our core mission is to leverage our expertise in drug delivery to create safe, effective, affordable products for high need indications.
2
Total investors
0
Early stage
2
Mid stage
0
Late stage
2015
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Turn Therapeutics (Nasdaq: TTRX)?
Turn Therapeutics (Nasdaq: TTRX) has 2 investors on record on gritt.io, 2 mid-stage.
When did Turn Therapeutics (Nasdaq: TTRX) last raise funding?
The most recent investment in Turn Therapeutics (Nasdaq: TTRX) recorded on gritt.io was in 2018.
When was Turn Therapeutics (Nasdaq: TTRX) founded?
Turn Therapeutics (Nasdaq: TTRX) was founded in 2015.
What industry is Turn Therapeutics (Nasdaq: TTRX) in?
Turn Therapeutics (Nasdaq: TTRX) operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Turn Therapeutics (Nasdaq: TTRX) based?
Turn Therapeutics (Nasdaq: TTRX) is headquartered in Westlake Village, United States.